Loading
The United States counts its cancer survivors each year and publishes the figure: 18.6 million in May 2025, projected to reach 22.4 million by 2035. Europe cannot produce an equivalent number, and that is a service-planning problem rather than a statistical one.
Counting survivors is what turns survivorship from a sentiment into a budget line, which is why the National Cancer Institute's Office of Cancer Survivorship exists to do it. Its published figures, read from its statistics page and dated there to May 2025: an estimated 18.6 million cancer survivors in the United States, about 5.4 per cent of the population, projected to grow to 22.4 million by 2035. Of survivors alive in 2025, 70 per cent have lived five or more years since diagnosis, 49 per cent ten or more years, and 22 per cent twenty or more; 79 per cent are aged 60 or older. Female breast cancer survivors are 23 per cent of the total at 4.3 million, prostate 19 per cent at 3.6 million, melanoma 9 per cent at 1.6 million and colorectal 8 per cent at 1.4 million, with people counted more than once if they have had more than one cancer. The underlying papers are the 2025 treatment and survivorship statistics and a 2024 prevalence analysis, both cited on that page.
Two things follow from the shape of the number rather than its size. The first is that this is overwhelmingly a population of older people with other illnesses, so late effects are superimposed on ordinary ageing and competing causes rather than appearing in isolation; the frailty and biological-ageing records on this front take that seriously. The second is that half of this population is more than ten years from diagnosis, which is well past the point at which any oncology service is still involved.
England's equivalent figure, from the 2013 national report, was around 1.8 million people living with a diagnosis of cancer, rising by over 3 per cent a year and projected to exceed 3 million by 2030. OnCo did not verify a current United Kingdom figure from a primary source in this round and prints none.
For Europe as a whole there is no such number. The European survivor-cohort record on this front quotes a 2024 scoping review's finding that information on the prevalence of childhood cancer survivors in Europe is fragmented and inconsistent, and states the consequence plainly: nobody knows accurately how many European survivors there are to plan services for. A health service cannot commission rehabilitation for a population whose size it does not know, which is why this record sits alongside the agenda record on counting late effects rather than in a statistics appendix.
Shares The founding of the National Coalition for Cancer Survivorship, and the word survivor, Recovery and rejuvenation roadmap: cure is not enough → survivorship gets a name → the cohorts that measured the cost → exercise proven as treatment → biological ageing measured and sold → repair, if anyone funds it and the tags rejuvenation, survivorship, history.
Shares The founding of the National Coalition for Cancer Survivorship, and the word survivor, Recovery and rejuvenation roadmap: cure is not enough → survivorship gets a name → the cohorts that measured the cost → exercise proven as treatment → biological ageing measured and sold → repair, if anyone funds it, National Cancer Institute (NIH), Survivorship and late effects are neglected and the tags rejuvenation, survivorship, history.
Shares The founding of the National Coalition for Cancer Survivorship, and the word survivor, Registries count diagnoses and deaths, and not what treatment left behind, Recovery and rejuvenation roadmap: cure is not enough → survivorship gets a name → the cohorts that measured the cost → exercise proven as treatment → biological ageing measured and sold → repair, if anyone funds it, Survivorship and late effects are neglected and the tags rejuvenation, survivorship, history.
Shares Rehabilitation is recommended everywhere and commissioned almost nowhere, Recovery and rejuvenation roadmap: cure is not enough → survivorship gets a name → the cohorts that measured the cost → exercise proven as treatment → biological ageing measured and sold → repair, if anyone funds it, Survivorship and late effects are neglected and the tags rejuvenation, survivorship, history.
Shares The founding of the National Coalition for Cancer Survivorship, and the word survivor, Recovery and rejuvenation roadmap: cure is not enough → survivorship gets a name → the cohorts that measured the cost → exercise proven as treatment → biological ageing measured and sold → repair, if anyone funds it and the tags survivorship, history.
Shares The founding of the National Coalition for Cancer Survivorship, and the word survivor, Recovery and rejuvenation roadmap: cure is not enough → survivorship gets a name → the cohorts that measured the cost → exercise proven as treatment → biological ageing measured and sold → repair, if anyone funds it and the tags survivorship, history.
Shares PanCareSurFup and the European survivor cohorts, Registries count diagnoses and deaths, and not what treatment left behind, Recovery and rejuvenation roadmap: cure is not enough → survivorship gets a name → the cohorts that measured the cost → exercise proven as treatment → biological ageing measured and sold → repair, if anyone funds it, Survivorship and late effects are neglected and the tags rejuvenation, survivorship.
Shares The founding of the National Coalition for Cancer Survivorship, and the word survivor, Recovery and rejuvenation roadmap: cure is not enough → survivorship gets a name → the cohorts that measured the cost → exercise proven as treatment → biological ageing measured and sold → repair, if anyone funds it, Survivorship and late effects are neglected and the tags rejuvenation, survivorship.